RecruitingNot ApplicableNCT07241559

Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain

Comparison of the Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided Thoracolumbar Interfascial 5% Dextrose Injection in Patients With Chronic Low Back Pain

Sponsor

Ankara City Hospital Bilkent

Enrollment

75 participants

Start Date

Nov 1, 2025

Study Type

INTERVENTIONAL

Summary

The aim of this study is to investigate the effects of thoracolumbar fascia mobilization and ultrasound-guided thoracolumbar interfascial 5% dextrose injection on pain, range of motion, disability, quality of life, proprioception, and fascial thickness and echogenicity in patients with nonspecific chronic low back pain. -Primary Objective: The primary objective is to evaluate the effects of these interventions on pain, functional status and range of motion. -Secondary Objective: The secondary objective is to assess the long-term effects on quality of life, proprioception, fascial thickness, and echogenicity.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

Male or female patients aged 18 to 65 years
Presence of low back pain lasting longer than 3 months
No adequate response to medical treatment
Voluntary participation in the study

Exclusion Criteria13

Age below 18 or above 65 years
Body mass index (BMI) greater than 30 kg/m²
Pregnancy or breastfeeding
Presence of coagulation disorders
History of spinal surgery
Presence of inflammatory or malignant diseases
Local infection at the spine or injection site
Presence of lumbar disc pathology causing radiculopathy
Presence of spinal stenosis, spondylolysis, or spondylolisthesis
Participation in physical therapy or any manual therapy within the past 6 months
Receiving lumbar injections within the past 6 months
History of allergy to injection materials
Refusal to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG5% dextrose injection

10 mL of 5% dextrose solution will be injected into the target area.

PROCEDUREMyofascial Release

Patients in this group will receive thoracolumbar fascia mobilization. A total of six sessions of myofascial release therapy will be administered twice per week for three weeks.

Locations(1)

Ankara Training and Research Hospital

Ankara, Altındağ, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07241559